O EGFRvIII mutation, the level of AREG expression identifies HNSCC patients
O EGFRvIII mutation, the level of AREG expression identifies HNSCC patients who are not responsive to combined cetuximab and docetaxel treatment. In agreement with this observation,16 we’ve got lately reported…